Overview

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the effect of salbutamol in comparison with ipratropium bromide on the geometry of central and peripheral airways and to correlate spirometric indices with the Computational Fluid Dynamics (CFD) based calculated airway volumes and resistances for both compounds.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Antwerp
Collaborator:
GlaxoSmithKline
Treatments:
Albuterol
Bromides
Ipratropium